- Home
- ARCT vs MCI Comparison
ARCT vs MCI Comparison
Compare ARCT & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- MCI
- Stock Information
- Founded
- ARCT 2013
- MCI 1971
- Country
- ARCT United States
- MCI United States
- Employees
- ARCT N/A
- MCI N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- MCI Trusts Except Educational Religious and Charitable
- Sector
- ARCT Health Care
- MCI Finance
- Exchange
- ARCT Nasdaq
- MCI Nasdaq
- Market Cap
- ARCT 373.7M
- MCI 436.4M
- IPO Year
- ARCT N/A
- MCI N/A
- Fundamental
- Price
- ARCT $14.94
- MCI $20.83
- Analyst Decision
- ARCT Strong Buy
- MCI
- Analyst Count
- ARCT 8
- MCI 0
- Target Price
- ARCT $52.83
- MCI N/A
- AVG Volume (30 Days)
- ARCT 443.2K
- MCI 40.4K
- Earning Date
- ARCT 08-04-2025
- MCI 01-01-0001
- Dividend Yield
- ARCT N/A
- MCI 8.46%
- EPS Growth
- ARCT N/A
- MCI N/A
- EPS
- ARCT N/A
- MCI 1.82
- Revenue
- ARCT $143,680,000.00
- MCI N/A
- Revenue This Year
- ARCT N/A
- MCI N/A
- Revenue Next Year
- ARCT $34.08
- MCI N/A
- P/E Ratio
- ARCT N/A
- MCI $9.88
- Revenue Growth
- ARCT 15.38
- MCI N/A
- 52 Week Low
- ARCT $8.04
- MCI $12.96
- 52 Week High
- ARCT $25.88
- MCI $19.24
- Technical
- Relative Strength Index (RSI)
- ARCT 60.54
- MCI 45.59
- Support Level
- ARCT $12.75
- MCI $20.84
- Resistance Level
- ARCT $15.83
- MCI $21.66
- Average True Range (ATR)
- ARCT 0.86
- MCI 0.55
- MACD
- ARCT 0.12
- MCI -0.13
- Stochastic Oscillator
- ARCT 71.10
- MCI 16.67
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About MCI Barings Corporate Investors
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.